Provided by Tiger Trade Technology Pte. Ltd.

PELTHOS THERAPEUTICS INC

25.51
-1.1500-4.31%
Post-market: 25.510.00000.00%19:30 EDT
Volume:21.64K
Turnover:569.12K
Market Cap:97.67M
PE:-0.97
High:28.47
Open:26.41
Low:25.00
Close:26.66
52wk High:37.50
52wk Low:18.19
Shares:3.83M
Float Shares:1.07M
Volume Ratio:0.93
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-26.3603
EPS(LYR):-23.0359
ROE:-333.84%
ROA:-49.98%
PB:-65.07
PE(LYR):-1.11

Loading ...

Company Profile

Company Name:
PELTHOS THERAPEUTICS INC
Exchange:
AMEX
Establishment Date:
2002
Employees:
92
Office Location:
4020 Stirrup Creek Drive,Suite 110,Durham,North Carolina,United States
Zip Code:
27703
Fax:
- -
Introduction:
Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound comprises CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as other fields of neuropathic pain. Chromocell Therapeutics Corporation was founded in 2002 and is based in Freehold, New Jersey.

Directors

Name
Position
Peter Greenleaf
Chairman of the Board and Independent Director
Scott Plesha
Chief Executive Officer,Director and President
Andrew Einhorn
Independent Director
Ezra Friedberg
Independent Director
Matthew Pauls
Independent Director
Richard Baxter
Independent Director
Richard Malamut
Independent Director
Todd Davis
Independent Director

Shareholders

Name
Position
Scott Plesha
Chief Executive Officer,Director and President
John M. Gay
Chief Financial Officer, Secretary and Treasurer
Sai Rangarao
Chief Commercial Officer